Protracted 'anti-addictive' effects of adolescent phenylpropanolamine exposure in C57BL/6J mice

Addiction Biology

Volumn 13, Issue 3-4, 2008, Pages 310-325

  Penzner, Jeffery H ^a   Thompson, Daria L ^a   Arth, Cory ^a   Fowler, Jaclyn K ^a   Ary, Alexis W ^a   Szumlinski, Karen K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adolescence; Catecholamines; Conditioned place preference; Glutamate; Phenylpropanolamine; Sensitization

Indexed keywords

CATECHOLAMINE; COCAINE; DOPAMINE; GLUTAMIC ACID; NORADRENALIN; PHENYLPROPANOLAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EXPOSURE; FEMALE; LOCOMOTION; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PERINATAL PERIOD; PRIORITY JOURNAL;

AGE FACTORS; AMINO ACIDS; ANIMALS; BEHAVIOR, ADDICTIVE; CATECHOLAMINES; COCAINE; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUTAMIC ACID; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; NARCOTICS; NEUROTRANSMITTER AGENTS; NUCLEUS ACCUMBENS; PHENOTYPE; PHENYLPROPANOLAMINE; SYMPATHOMIMETICS;

EID: 49349104329     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2008.00101.x     Document Type: Article

References (83)

1. Achat-Mendes C, Anderson KL, Itzhak Y (2003) Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood. Neuropharmacology 45 : 106 115.
2. Adriani W, Granstrem O, Macri S, Izykenova G, Dambinova S, Laviola G (2004) Behavioral and neurochemical vulnerability during adolescence in mice: studies with nicotine. Neuropsychopharmacology 29 : 869 878.
3. Adriani W, Laviola G (2000) A unique hormonal and behavioral hyporesponsivity to both forced novelty and d-amphetamine in periadolescent mice. Neuropharmacology 39 : 334 346.
4. Andersen S (2003) Trajectories of brain development: point of vulnerability or window of opportunity? Neurosci Biobehav Rev 27 3 18.
5. Andersen SL, Arvanitogiannis A, Pliakas AM, LeBlanc C, Carlezon WA Jr. (2002) Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci 5 : 13 14.
6. Augustyniak PN, Kourrich S, Rezazadeh SM, Stewart J, Arvanitogiannis A (2006) Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder. Behav Brain Res 167 : 379 382.
7. Bardo MT, Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153 : 31 43.
8. Bartolome JV, Kavlock RJ, Cowdery T, Orband-Miller I, Slotkin TA (1987) Development of adrenergic receptor binding sites in brain regions of the neonatal rat: effects of prenatal or postnatal exposure to methylmercury. Neurotoxicity 8 : 1 14.
9. Berger-Sweeney J, Hohmann CF (1997) Behavioral consequences of abnormal cortical development: insights into developmental disabilities. Behav Brain Res 86 : 121 142.
10. Bolanos CA, Glatt SJ, Jackson D (1998) Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioral and neurochemical analysis. Dev Brain Res 111 : 25 33.
11. Brandon CL, Marinelli M, Baker LK, White FJ (2001) Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 25 : 651 661.
12. Carlezon WA Jr., Konradi C (2004) Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules. Neuropharmacology 47 (Suppl 1 47 60.
13. Carlezon WA Jr., Mague SC, Andersen SL (2003) Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 54 : 1330 1337.
14. Chait LD, Uhlenhuth EH, Johanson CE (1998) Phenylpropanolamine: reinforcing and subjective effects in normal human volunteers. Psychopharmacology 96 : 212 217.
15. Cirulli F, Laviola G (2004) Paradoxical effects of D-amphetamine in infant and adolescent mice: role of gender and environmental risk factors. Neurosci Biobehav Rev 24 : 73 84.
16. Collins SL, Izenwasser S (2002) Cocaine differentially regulates both behavior and neurochemistry in periadolescent versus adult rats. Dev Brain Res 138 : 27 34.
17. Crews F, He J, Hodge C (2007) Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav 86 : 189 199.
18. Dafny N, Yang PB (2006) The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: a review of its locomotor effects. Brain Res Bull 68 : 393 405.
19. Dalia A, Uretsky NJ, Wallace LJ (1998) Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity. Brain Res 788 : 111 117.
20. Daws LC, Lopez R, Frazer A (1998) Effects of antidepressant treatment on inhibitory avoidance behavior and amygdaloid beta-adrenoreceptors in rats. Neuropsychopharmacology 19 : 300 313.
21. Ehrlich ME, Sommer J, Canas E, Unterwald EM (2002) Periadolescent mice show enhanced ΔFosB upregulation in response to cocaine and amphetamine. J Neurosci 22 : 9155 9159.
22. Eisenberg MS, Maher TJ, Silverman HI (1987) A comparison of the effects of phenylpropanolamine, d-amphetamine and d-norpseudoephedrine on open-field locomotion and food intake in the rat. Appetite 9 : 31 37.
23. Everitt BJ, Wolf ME (2002) Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 22 : 3312 3320.
24. Gardner EL, Ashby CR Jr. (2000) Heterogeneity of the mesotelencephalic dopamine fibers: physiology and pharmacology. Neurosci Biobehav Rev 24 : 115 118.
25. Golembiowska K, Zylewska A (1999) Effect of antidepressant drugs on veratridine-evoked glutamate and aspartate release in rat prefrontal cortex. Pol J Pharmacol 51 : 63 70.
26. Guerriero RM, Hayes MM, Dhaliwal SK, Ren JQ, Kosofsky BE (2006) Preadolescent methylphenidate versus cocaine treatment differ in the expression of cocaine-induced locomotor sensitization during adolescence and adulthood. Biol Psychiatry 60 : 1171 1180.
27. Happe HK, Bylund DB, Murrin LC (1999) Alpha-2 adrenergic receptor functional couple to G proteins in rat brain during postnatal development. J Pharmacol Exp Ther 288 : 1134 1142.
28. Hemmati P, Shilliam CS, Hughes ZA, Shah AJ, Roberts JC, Atkins AR, Hunter AJ, Heidbreder CA (2001) In vivo characterization of basal amino acid levels in subregions of the rat nucleus accumbens: effect of a dopamine D(3)/D(2) agonist. Neurochem Int 39 : 199 208.
29. Hoffman BB (2001) Catecholamines, sympathomimetics and adrenergic receptor antagonists. In : Hardman JG, Limbird LE, Gilman AG, eds. Goodman and Gilman's the Pharmacological Basis of The Rapeutics, pp. 215 268. New York : McGraw-Hill.
30. Ioannides-Demos LL, Proietto J, Tonkin AM, McNeil JJ (2006) Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf 29 : 277 302.
31. Kalivas PW, Duffy P (1997) Dopamine regulation of extracellular glutamate in the nucleus accumbens. Brain Res 761 : 173 177.
32. Kalivas PW, McFarland K (2003) Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology 168 : 44 56.
33. Kalivas PW, Volkow N, Seamans J (2005) Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 45 : 647 650.
34. Kanfer I, Dowse R, Vuma V (1993) Pharmacokinetics of oral decongestants. Pharmacotherapy 13 : 116S 128S.
35. Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199 : 649 661.
36. Konkol RJ, Bendeich EG, Breese GR (1978) A biochemical and morphological study of the altered growth pattern of central catecholamine neurons following 6-hydroxydopamine. Brain Res 140 : 125 135.
37. Koob G, Kreek MJ (2007) Stress, dysregulation of drug reward pathways and the transition to drug dependence. Am J Psychiatry 164 : 1149 1159.
38. Kushner RF, Manzano H (2002) Obesity pharmacology: past, present and future. Curr Opin Gastroenterol 18 : 213 220.
39. Laviola G, Adriani W, Terranova ML, Gerra G (1999) Psychobiological risk factors for vulnerability to psychostimulants in human adolescent and adult animals. Neurosci Biobehav Rev 23 : 993 1010.
40. Lee F, Stafford I, Hoebel BG (1989) Similarities between the stimulus properties of phenylpropanolamine and amphetamine. Psychopharmacology 97 : 410 412.
41. Loizou LA, Salt P (1970) Regional changes in monoamines of the rat brain during postnatal development. Brain Res 20 : 467 470.
42. Lominac KD, Kapasova Z, Hannun RA, Patterson C, Middaugh LD, Szumlinski KK (2006) Behavioral and neurochemical interactions between Group 1 mGluR antagonists and ethanol: potential insight into their anti-addictive properties. Drug Alcohol Depend 85 : 142 156.
43. Mague SD, Andersen SL, Carlezon WA Jr. (2005) Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats. Biol Psychiatry 57 : 120 125.
44. Marek GJ, Aghajanian GK (1999) 5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur J Pharmacol 367 : 197 206.
45. Mariathasan EA, Stolerman IP (1992) Drug discrimination studies in rats with caffeine and phenylpropanolamine administered separately and as mixtures. Psychopharmacology 109 : 99 106.
46. Markus EJ, Petit TL (1987) Neocortical synaptogenesis, aging and behavior: lifespan development in the motor-sensory system of the rat. Exp Neurol 96 : 262 L-278.
47. McMahon LR, Wellman PJ (1996) Effects of systemic phenylpropanolamine and fenfluramine on serotonin activity within rat paraventricular hypothalamus. Physiol Behav 59 : 63 69.
48. Mittleman G, Rushing PA, Winders SE (1993) Effects of phenylpropanolamine on regulatory and nonregulatory ingestion in adult rats. Physiol Behav 54 : 515 521.
49. Morris MJ, Dausse JP, Devynck MA, Meyer P (1980) Ontogeny of α1 and α2-adrenoreceptors in rat brain. Brain Res 190 : 268 271.
50. Muller CP, Carey RJ, Huston JP, De Souza Silva MA (2007) Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors. Prog Neurobiol 81 : 133 178.
51. Murrin LC, Sanders JD, Bylund DB (2007) Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults. Biochem Pharmacol 73 : 1225 1236.
52. Naclerio RM (1991) Allergic rhinitis. N Engl J Med 325 : 860 869.
53. Niculescu M, Ehrlich ME, Unterwald EM (2005) Age-specific behavioral responses to psychostimulants in mice. Pharmacol Biochem Behav 82 : 280 288.
54. Patrick KS, Kilts CD, Breese GR (1981) Synthesis and pharmacology of hydroxylated metabolites of methylphenidate. J Med Chem 24 : 1237 1240.
55. Rebec GV, Sun W (2005) Neuronal substrates of relapse to cocaine-seeking behavior: role of prefrontal cortex. J Exp Anal Behav 84 : 653 666.
56. Reinstein DK, Isaacson RL (1977) Clonidine sensitivity in the developing rat. Brain Res 135 : 378 382.
57. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237 : 1219 1223.
58. Rothman RB, Vu N, Partilla JS, Roth BL, Hufeisen SJ, Compton-Toth BA, Birkes J, Young R, Glennon RA (2003) In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates. J Pharmacol Exp Ther 307 : 138 145.
59. Rushing PA, Winders SE, Mittleman G (1993) Effects of phenylpropanolamine infusion and withdrawal on body weight and dietary composition in male and female rats. Physiol Behav 54 : 523 530.
60. Sanders JD, Happe HK, Bylund DB, Murrin LC (2005) Development of the norepinephrine transporter in the rat CNS. Neuroscience 130 : 107 117.
61. Schlicker E, Gothert M (1998) Interactions between the presynaptic alpha2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones. Brain Res Bull 47 : 129 132.
62. Schramm-Saptya NL, Pratt AR, Winder DG (2004) Effects of periadolescent versus adult cocaine exposure on cocaine conditioned place preference and motor sensitization in mice. Psychopharmacology 173 : 41 49.
63. Simons FE, Gu X, Watson WT, Simons KJ (1996) Pharmacokinetics of the orally administered decongestants pseudoephedrine and phenylpropanolamine in children. J Pediatr 129 : 729 734.
64. Smith MBH, Feldman W (1993) Over-the-counter cold medications: a critical review of clinical trials between 1950 and 1991. JAMA 269 : 2258 2263.
65. Spear LP, Brake SC (1983) Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats. Dev Psychobiol 16 : 83 109.
66. Starke K (2001) Presynaptic autoreceptors in the third decade: focus on alpha2-adrenoceptors. J Neurochem 78 : 685 693.
67. Subhash MN, Nagaraja MR, Sharada S, Vinod KY (2003) Cortical alpha-adrenoreceptor downregulation by tricyclic antidepressants in the rat brain. Neurochem Int 43 : 603 609.
68. Szumlinski KK, Ary AW, Lominac KD, Klugmann M, Kippin TE (2007a) Accumbens Homer2 overexpression facilitates alcohol-induced neuroplasticity in C57BL/6J mice. Neuropsychopharmacology (doi:10.1038/sj.npp.1301473).
69. Szumlinski KK, Dehoff MH, Kang SH, Frys KA, Lominac KD, Rohrer J, Griffin W III., Klugmann M, Toda S, Champtiaux NP, Berry T, Shealy S, During M, Middaugh LD, Worley PF, Kalivas PW (2004) Homer proteins regulate vulnerability to cocaine. Neuron 43 : 401 413.
70. Szumlinski KK, Diab ME, Friedman R, Henze LM, Lominac KD, Bowers MS (2007b) Accumbens neurochemical adaptations produced by binge-like alcohol consumption. Psychopharmacology 190 : 415 431.
71. Szumlinski KK, Herrick-Davis K, Teitler M, Maisonneuve IM, Glick SD (2000) Behavioural sensitization to cocaine is dissociated from changes in striatal NMDA receptor levels. Neuroreport 11 : 2785 2788.
72. Szumlinski KK, Liu A, Penzner JH, Lominac KD (2007c) Protracted 'pro-addictive' phenotype produced in mice by pre-adolescent phenylpropanolamine. Neuropsychopharmacology 32 : 1760 1773.
73. Szumlinski KK, Price KL, Frys KA, Middaugh LD (2002) Unconditioned and conditioned factors contribute to the 'reinstatement' of cocaine place conditioning following extinction in C57BL/6 mice. Behav Brain Res 136 : 151 160.
74. Szumlinski KK, Tieu A, Renton R, Liu A, Lominac KD (2006) Pre-adolescent phenylpropanolamine produces persistent perturbations in cocaine-induced increases in accumbens levels of catecholamines and amino acids. Soc Neurosci Abstr 393 : 21.
75. Tarazi FI, Tomasini EC, Baldessarini RJ (1999) Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: an autoradiographic study. Dev Neurosci 21 : 43 49.
76. Teicher MH, Andersen SL, Hostetter JC Jr. (1995) Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Dev Brain Res 89 : 167 172.
77. Thanos PK, Michaelides M, Benveniste H, Wang GJ, Volkow ND (2007) Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents. Pharmacol Biochem Behav 87 : 426 433.
78. Tzschentke TM (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12 : 227 462.
79. Wellman PJ (1990) The pharmacology of the anorexic effect of phenylpropanolamine. Drugs Exp Clin Res 16 : 487 495.
80. Wellman PJ, Shelton K, Schenk S (1989) Self-administration of phenylpropanolamine (PPA) by rats previously trained to self-administer amphetamine. Pharmacol Biochem Behav 34 : 187 191.
81. Winzer-Serhan UH, Raymon HK, Broide RS, Chen Y, Leslie FM (1997) Expression of α2 adrenoreceptors during rat brain development-I. α2A messenger RNA expression. Neuroscience 76 : 241 260.
82. Woolverton WL, Johanson CE, de la Garza R, Ellis S, Seiden LS, Schuster CR (1986) Behavioral and neurochemical evaluation of phenylpropanolamine. J Pharmacol Exp Ther 237 : 926 930.
83. Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F (2000) Trends in the prescribing of psychotropic medication to preschoolers. JAMA 283 : 1025 1030.